IncRNA's role in triple-negative breast cancer provides potential inroads to much-needed therapies Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it's also one of the most curable. The exception is a particularly aggressive variant known as triple-negative breast cancer (TNBC). It accounts for 10% to 15% of all breast cancer cases. It disproportionately affects younger and African American women.
https://medicalxpress.com/news..../2025-06-incrna-role